The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Identifying early-phase clinical trial (EP-CT) participants at risk for poor outcomes.
 
Debra Lundquist
No Relationships to Disclose
 
Rachel Jimenez
Employment - Biogen (I)
Stock and Other Ownership Interests - Biogen (I)
Research Funding - Focal Therapeutics
 
Megan Healy
No Relationships to Disclose
 
Andrew Johnson
No Relationships to Disclose
 
Sienna Durbin
No Relationships to Disclose
 
Virginia Capasso
No Relationships to Disclose
 
Casandra McIntyre
No Relationships to Disclose
 
Barbara J. Cashavelly
No Relationships to Disclose
 
Dejan Juric
Consulting or Advisory Role - Eisai; EMD Serono; Genentech; Ipsen; MapKure; Novartis; Petra Pharma; Syros Pharmaceuticals; Vibliome Therapeutics
Research Funding - Amgen (Inst); Eisai (Inst); EMD Serono (Inst); Genentech (Inst); Infinity Pharmaceuticals (Inst); InventisBio (Inst); Novartis (Inst); Pfizer (Inst); Placon (Inst); Syros Pharmaceuticals (Inst); Takeda (Inst); Takeda (Inst)
 
Ryan David Nipp
No Relationships to Disclose